Humana (HUM) and UnitedHealth Group (UNH) represent two prominent players in the U.S. managed healthcare industry, making them relevant for investors and traders seeking exposure to health insurance and care delivery. This comparison examines their business profiles, recent performance trends, and relative positioning in the current market environment. It is particularly useful for those evaluating sector allocation, momentum shifts, or diversification within healthcare equities, providing a factual basis for assessing contrasts in scale, growth drivers, and risk profiles without favoring either stock.
Humana Inc. (HUM) focuses primarily on Medicare Advantage plans, commercial insurance, and value-based care through its CenterWell segment. In recent market activity, the stock has posted substantial year-to-date gains near 61%, outperforming broader indices amid strong membership expansion. Q2 2026 results showed adjusted earnings per share of $7.61, exceeding estimates, with revenues rising 26.2% year over year to $40.9 billion, supported by premium growth and Medicare Advantage membership increases of 23.8%. Sentiment benefited from operational updates and analyst target raises, though guidance adjustments for full-year earnings introduced caution around medical costs. Recent weeks have featured price fluctuations within an overall upward trajectory, influenced by these earnings dynamics and sector-wide utilization trends.
UnitedHealth Group Incorporated (UNH) operates a diversified model encompassing UnitedHealthcare insurance and Optum health services, pharmacy benefits, and data analytics. The stock has experienced recovery in recent periods, with year-to-date returns around 16-19% following earlier volatility. Q2 2026 delivered revenues of $112 billion and adjusted earnings per share of $6.38, alongside an improved medical care ratio of 86.7%. Performance has been supported by margin expansion efforts, dividend authorizations, and service expansions such as behavioral health programs. Recent market activity reflects stabilization, with the larger market capitalization providing a buffer compared to peers, as operational resilience and cost management initiatives shaped investor positioning amid ongoing healthcare sector pressures.
Tickeron maintains a curated Trending AI Robots section that highlights select AI trading bots from its extensive library of hundreds of bots capable of trading thousands of tickers. Only those demonstrating strong alignment with prevailing market conditions, consistent performance metrics, and suitable risk profiles earn placement in this trending roster. Available bots span diverse trading styles, strategies, timeframes, and ticker sets, with performance statistics varying widely across backtested and live results—often including ranges of win rates, drawdowns, and returns that reflect their specialized approaches. This resource allows traders to explore automated strategies tailored to equities like those in healthcare. Review the Trending AI Robots page for current selections and detailed analytics.
Humana (HUM) and UnitedHealth Group (UNH) differ markedly in scale, with UNH holding a market capitalization exceeding $340 billion versus HUM's approximately $47-49 billion. Business models contrast as well: HUM emphasizes Medicare Advantage and integrated care delivery, yielding higher recent revenue growth rates near 26% in Q2, while UNH leverages diversification across insurance and Optum services for steadier cash flows and margin recovery. Recent momentum favors HUM in percentage terms due to membership gains, whereas UNH demonstrates resilience through medical cost ratio improvements and capital returns. Risk factors include HUM's sensitivity to Stars program outcomes and guidance revisions, balanced against UNH's exposure to regulatory scrutiny and utilization trends. Sector exposure remains comparable within managed care, yet market sentiment has rewarded HUM's growth narrative more aggressively in recent weeks, while UNH trades at comparatively lower forward valuations, presenting trade-offs between expansion potential and established stability.
Based on observable factors such as trend consistency in membership and earnings delivery, relative stability from scale, and positioning amid cost management catalysts, Tickeron’s AI models currently assign a modestly higher probabilistic preference to UnitedHealth Group (UNH) for balanced exposure in the near term. Humana (HUM) shows compelling momentum but carries elevated variability in guidance outcomes. This assessment draws from recent performance patterns rather than forecasts and remains subject to evolving market data.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
HUM | UNH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 85 | 80 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 9 Undervalued | 4 Undervalued | |
PROFIT vs RISK RATING 1..100 | 97 | 100 | |
SMR RATING 1..100 | 98 | 57 | |
PRICE GROWTH RATING 1..100 | 37 | 46 | |
P/E GROWTH RATING 1..100 | 9 | 11 | |
SEASONALITY SCORE 1..100 | 33 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
UNH's Valuation (4) in the Managed Health Care industry is in the same range as HUM (9). This means that UNH’s stock grew similarly to HUM’s over the last 12 months.
HUM's Profit vs Risk Rating (97) in the Managed Health Care industry is in the same range as UNH (100). This means that HUM’s stock grew similarly to UNH’s over the last 12 months.
UNH's SMR Rating (57) in the Managed Health Care industry is somewhat better than the same rating for HUM (98). This means that UNH’s stock grew somewhat faster than HUM’s over the last 12 months.
HUM's Price Growth Rating (37) in the Managed Health Care industry is in the same range as UNH (46). This means that HUM’s stock grew similarly to UNH’s over the last 12 months.
HUM's P/E Growth Rating (9) in the Managed Health Care industry is in the same range as UNH (11). This means that HUM’s stock grew similarly to UNH’s over the last 12 months.
| HUM | UNH | |
|---|---|---|
| RSI ODDS (%) | N/A | 4 days ago 50% |
| Stochastic ODDS (%) | 2 days ago 67% | 2 days ago 68% |
| Momentum ODDS (%) | 2 days ago 71% | 2 days ago 67% |
| MACD ODDS (%) | 2 days ago 67% | 2 days ago 55% |
| TrendWeek ODDS (%) | 2 days ago 63% | 2 days ago 59% |
| TrendMonth ODDS (%) | 2 days ago 63% | 2 days ago 57% |
| Advances ODDS (%) | 2 days ago 63% | 2 days ago 56% |
| Declines ODDS (%) | 5 days ago 66% | 4 days ago 53% |
| BollingerBands ODDS (%) | 2 days ago 68% | 2 days ago 67% |
| Aroon ODDS (%) | 2 days ago 68% | 2 days ago 54% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HUM’s FA Score shows that 2 FA rating(s) are green while UNH’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HUM’s TA Score shows that 5 TA indicator(s) are bullish while UNH’s TA Score has 4 bullish TA indicator(s).
HUM (@Managed Health Care) experienced а +3.03% price change this week, while UNH (@Managed Health Care) price change was -0.08% for the same time period.
The average weekly price growth across all stocks in the @Managed Health Care industry was -2.42%. For the same industry, the average monthly price growth was -6.22%, and the average quarterly price growth was +64.65%.
HUM is expected to report earnings on Nov 06, 2026.
UNH is expected to report earnings on Oct 13, 2026.
Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
A.I.dvisor indicates that over the last year, HUM has been loosely correlated with UNH. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if HUM jumps, then UNH could also see price increases.
A.I.dvisor indicates that over the last year, UNH has been closely correlated with ELV. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if UNH jumps, then ELV could also see price increases.